Stock (Symbol) |
Stryker (SYK) |
Stock Price |
$94 |
Sector |
| Healthcare |
Data is as of |
| December 7, 2015 |
Expected to Report |
| Jan 26 |
Company Description |
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.Source: Thomson Financial |
Sharek’s Take |
One Year Chart |
This stock was hotter last qtr. The P/E was 20 compared to 17 now. I didn’t think SYK was worth 20x earnings, and investors sent the shares lower after SYK reported profits on 10/22. The strong dollar really takes a bite out of stock growth with these multinationals. Even if they grow profits 10%, it’s not enough for hungry investors. So these stocks just meander. |
Fair Value |
Last qtr I felt SYK was selling for 20x earnings and I felt it worth 17 times earnings. Now its selling at 17x 2016 profit estimates. Yes, that’s 2016. So I don’t see any upside next year. |
Bottom Line |
Stryker is known for its replacement hips and hospital beds, which are always in demand, giving this stock a high degree of certainty and consistency. Overall the company is growing profits around 10% and you get a 1.6% yield. Those are good numbers. At 17x earnings the stock is fairly valued at this time, but is a solid choice for large trusts as it provides safety, a dividend and long-term growth. |
Power Rankings |
Growth Stock Portfolio
N/AAggressive Growth Portfolio N/AConservative Stock Portfolio N/A |

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.
This stock was hotter last qtr. The P/E was 20 compared to 17 now. I didn’t think SYK was worth 20x earnings, and investors sent the shares lower after SYK reported profits on 10/22. The strong dollar really takes a bite out of stock growth with these multinationals. Even if they grow profits 10%, it’s not enough for hungry investors. So these stocks just meander.
Last qtr I felt SYK was selling for 20x earnings and I felt it worth 17 times earnings. Now its selling at 17x 2016 profit estimates. Yes, that’s 2016. So I don’t see any upside next year.
Stryker is known for its replacement hips and hospital beds, which are always in demand, giving this stock a high degree of certainty and consistency. Overall the company is growing profits around 10% and you get a 1.6% yield. Those are good numbers. At 17x earnings the stock is fairly valued at this time, but is a solid choice for large trusts as it provides safety, a dividend and long-term growth.